MediSYS Leverages Alpha II Registry to Improve Quality Measure Reporting for Providers
Jan 31, 2017 13:11 pm UTC| Business
TALLAHASSEE, Fla., Jan. 31, 2017 -- Alpha II, LLC, a leading developer of software platforms, software as a service and publications that support the healthcare revenue cycle, announced today it has signed an agreement...
StarChip’s Secure IC for Bank Cards Enabled by SST’s SuperFlash® Technology
Jan 31, 2017 13:10 pm UTC| Business
CHANDLER, Ariz., Jan. 31, 2017 -- Microchip Technology Inc. (NASDAQ:MCHP), a leading provider of microcontroller, mixed-signal, analog and Flash-IP solutions, through its Silicon Storage Technology (SST) subsidiary,...
Biloxi Public School District Selects HVE for Desktop Virtualization
Jan 31, 2017 13:02 pm UTC| Business
SAN JOSE, Calif., Jan. 31, 2017 -- Sphere 3D Corp. (NASDAQ:ANY), a containerization, virtualization, and data management solutions provider, today announced that Biloxi Public Schools (BPS) has selected HVE ConneXions...
Jan 31, 2017 13:02 pm UTC| Business
Press release, Helsinki, 31 January 2017, at 3pm Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), a medical technology company with a pioneering navigated non-invasive brain stimulation system, announces...
Jan 31, 2017 13:01 pm UTC| Business
Net revenues were a record $599 million in the fourth quarter of 2016, up 12% year-over-year. Subscription and recurring revenues2 in the fourth quarter of 2016 represented 75% of total net revenues. Revenues in...
Tyme Announces Issuance of Second Core Platform Patent
Jan 31, 2017 13:01 pm UTC| Business
NEW YORK, Jan. 31, 2017 -- Tyme Technologies, Inc. (OTCQB:TYMI), a clinical stage biotechnology company developing cancer therapeutics that are designed to be effective across multiple tumor types, announced that the...
Tyme Announces Issuance of Second Core Platform Patent
Jan 31, 2017 13:01 pm UTC| Business
NEW YORK, Jan. 31, 2017 -- Tyme Technologies, Inc. (OTCQB:TYMI), a clinical stage biotechnology company developing cancer therapeutics that are designed to be effective across multiple tumor types, announced that the...